IBS is a chronic, fluctuating disorder that continues to be the subject of considerable research. 2010 saw some key advances across all aspects of IBS, including further advances in our understanding of the pathophysiology, diagnosis and treatment of this condition.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Moxibustion in the management of irritable bowel syndrome: systematic review and meta-analysis
BMC Complementary and Alternative Medicine Open Access 02 October 2013
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Mertz, H. et al. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology 118, 842–848 (2000).
Bonaz, B. et al. Central processing of rectal pain in patients with irritable bowel syndrome: an fMRI study. Am. J. Gastroenterol. 97, 654–661 (2002).
Tillisch, K., Mayer, E. A. & Labus, J. S. Quantitative meta-analysis identifies brain regions activated during rectal distension in irritable bowel syndrome. Gastroenterology doi:10.1053/j.gastro.2010.07.053 (2010).
Thabane, M., Kottachchi, D. & Marshall, J. K. Systematic review and meta-analysis: incidence and prognosis of post-infectious irritable bowel syndrome. Aliment. Pharmacol. Ther. 26, 535–544 (2007).
Marshall, J. K. et al. Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut 59, 605–611 (2010).
Chey, W. D. et al. The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial. Am. J. Gastroenterol. 105, 859–865 (2010).
Lembo, A. J. et al. Efficacy of linaclotide for patients with chronic constipation. Gastroenterology 138, 886–895 (2010).
Johnston, J. M. et al. Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome. Gastroenterology doi:10.1053/j.gastro.2010.08.041 (2010).
Klooker, T. K. et al. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome. Gut 59, 1213–1221 (2010).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
N. J. Talley has acted as a consultant for Ironwood Pharmaceuticals and Novartis. A. C. Ford declares no competing interests.
Rights and permissions
About this article
Cite this article
Ford, A., Talley, N. Advances in pathophysiology, diagnosis and treatment. Nat Rev Gastroenterol Hepatol 8, 76–78 (2011). https://doi.org/10.1038/nrgastro.2010.216
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2010.216
This article is cited by
-
Moxibustion in the management of irritable bowel syndrome: systematic review and meta-analysis
BMC Complementary and Alternative Medicine (2013)
-
Liens entre alimentation et syndrome de l’intestin irritable
Côlon & Rectum (2013)